Latin America Onychomycosis Market Size & Outlook

The onychomycosis market in Latin America is expected to reach a projected revenue of US$ 311.4 million by 2030. A compound annual growth rate of 5.8% is expected of Latin America onychomycosis market from 2024 to 2030.
Revenue, 2023 (US$M)
$209.5
Forecast, 2030 (US$M)
$311.4
CAGR, 2024 - 2030
5.8%
Report Coverage
Latin America

Latin America onychomycosis market highlights

  • The Latin America onychomycosis market generated a revenue of USD 209.5 million in 2023.
  • The market is expected to grow at a CAGR of 5.8% from 2024 to 2030.
  • In terms of segment, topical was the largest revenue generating treatment in 2023.
  • Topical is the most lucrative treatment segment registering the fastest growth during the forecast period.
  • Country-wise, Mexico is expected to register the highest CAGR from 2024 to 2030.


Latin America data book summary

Market revenue in 2023USD 209.5 million
Market revenue in 2030USD 311.4 million
Growth rate5.8% (CAGR from 2023 to 2030)
Largest segmentTopical
Fastest growing segmentTopical
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationOral, Topical
Key market players worldwideGSK PLC, Abbott Laboratories, Pfizer Inc, Bausch Health Companies Inc, Bayer AG, Teva Pharmaceutical Industries Ltd, Cipla Ltd DR, Merck & Co Inc, Novartis AG ADR, Sun Pharmaceutical Industries


Other key industry trends

  • In terms of revenue, Latin America region accounted for 5.9% of the global onychomycosis market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 1,201.0 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Onychomycosis Market Companies

Name Profile # Employees HQ Website

Latin America onychomycosis market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to onychomycosis market will help companies and investors design strategic landscapes.


Topical was the largest segment with a revenue share of 57.66% in 2023. Horizon Databook has segmented the Latin America onychomycosis market based on oral, topical covering the revenue growth of each sub-segment from 2018 to 2030.


The onychomycosis market in Latin America is witnessing growth due to various factors such as the high prevalence of fungal nail infections as a result of the high prevalence of diabetes and HIV.

Increasing awareness about onychomycosis and its impact on health leads to a rising demand for effective treatments. The rapidly aging population in Latin America, prone to onychomycosis, also contributes to market expansion.

The warm and humid climate in many Latin American countries creates favorable conditions for the growth of fungi, contributing to a higher incidence of nail infections in the region.

Reasons to subscribe to Latin America onychomycosis market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Latin America onychomycosis market databook

  • Our clientele includes a mix of onychomycosis market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America onychomycosis market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America onychomycosis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Latin America onychomycosis market size, by country, 2018-2030 (US$M)

Latin America Onychomycosis Market Outlook Share, 2023 & 2030 (US$M)

Latin America onychomycosis market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more